The MarketLooks: World Market for Prescription Drugs to Treat Sexual Dysfunction in Men

• The busy executive, researcher or product manager who needs top line statistics today in an easy to read, easy to digest format
  
• The busy information professional who regularly juggles a multitude of basic requests for high-level market information from information patrons.
  
• The consultant or analyst who needs to ramp up on a new market or demographic area quickly
  
  

Abstract from full report:

This Kalorama Information report—Men’s Health: The World Market for Current and Emerging Drug Therapies—focuses on treatment segments in which men are affected. These segments include:

· Men’s Cancer

· Sexual Function

· Sexually Transmitted Diseases

· Urinary Conditions

· Andropause

The report covers drugs that are used for the treatment of conditions affecting men, including prostate cancer, impotence, and BPH; and areas where diseases and men’s health are a major concern including HIV, herpes, and urinary incontinence. Revenues for product segments include the amount estimated for use in men, for example in the area of BPH 100 percent of revenues are attributed to use in men and between 20 and 30 percent of the total urinary incontinence is calculated for the men’s health market.

The report includes statistical information for conditions and diseases affecting the men worldwide, with special emphasis on the U.S. market. Each segment provides an overview, descriptions of products on the market, products in research and development, market estimates and forecasts, and competitive analysis of leading providers. In addition to above-mentioned information, the report includes current issues and trends affecting the industry and identifies trends that may arise in the future.